Max Robotics — Global Service Robot Directory + US Certification

About

Ciprian Muresan is a urological surgeon whose research centers on advancing surgical techniques for prostate cancer, with a particular focus on improving patient quality of life through enhanced urinary continence outcomes. His major contributions lie in the evaluation and refinement of Retzius-sparing robot-assisted radical prostatectomy (RS-RARP), a nerve-sparing approach that preserves anterior pelvic structures to accelerate recovery. In his most cited work (2023, 7 citations), Muresan demonstrated that surgeon experience and center caseload significantly influence continence recovery after RS-RARP, providing crucial benchmarks for surgical training and institutional implementation. He further identified membranous urethral length as the single independent predictor of 12-month continence recovery (2024, 6 citations), a finding that offers a preoperative tool for patient counseling and surgical planning. Notably, his 2023 study (5 citations) validated that RS-RARP can achieve adequate oncological and functional outcomes even in medium-volume centers with no prior experience, challenging the notion that this technique is exclusive to high-volume institutions. With over 18 citations across his key works, Muresan’s research bridges the gap between specialized surgical innovation and broader clinical adoption, making him a valuable voice in evidence-based urological oncology.